Navigation Links
Pradaxa Lawsuit News: Bernstein Liebhard LLP Comments on Study Findings Regarding Use of Pradaxa in Mechanical Heart Valve Patients
Date:9/8/2013

New York, New York (PRWEB) September 08, 2013

As Pradaxa lawsuit (http://www.pradaxalawsuithelp.com/) claims continue to move forward in courts around the country, Bernstein Liebhard LLP notes that a newly-published study has reported that Pradaxa is no safer or effective than warfarin when used to treat people with mechanical heart valves. The study, called RE-ALIGN, was halted early after it became apparent that Pradaxa patients were more likely to suffer thromboembolic events, including strokes, heart attacks and blood clots, as well as internal bleeding, compared to those treated with warfarin, a blood thinner that has been on the market for decades. The study appears in the September 1, 2013 issue of the New England Journal of Medicine.*

“It’s disturbing to note that this study had to be halted early because of the high rates of Pradaxa side effects, including internal bleeding. This research is just another reminder that the risks and benefits of Pradaxa need to be more fully evaluated,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Pradaxa lawsuit evaluations to patients who suffered serious internal bleeding while using this blood thinner.

Pradaxa Lawsuits
Pradaxa, which is used to prevent strokes in people with a heart-rhythm disorder known as atrial fibrillation, was approved by the U.S. Food & Drug Administration (FDA) in October 2010. In December, shortly after the RE-ALIGN trial was halted, the FDA announced that a new contraindication was being added to the Pradaxa label to warn against its use in patients with mechanical heart valves.

According to a report from Bloomberg.com, Pradaxa was touted as an improvement over warfarin, a blood thinner sold under the brand name Coumadin. However, unlike warfarin, there is no readily available antidote to stop Pradaxa bleeding.** According to the Institute for Safe Medicine Practices (ISMP), an analysis of hemorrhage cases reported to the FDA during the second quarter of 2012 found that Pradaxa bleeding is 5 times more likely to result in death compared to warfarin bleeding.***

According to court documents, more than 1,470 Pradaxa lawsuits have been filed in a multidistrict litigation underway in U.S. District Court, Southern District of Illinois on behalf of alleged victims of Pradaxa bleeding. All of the complaints accuse Boehringer Ingelheim of selling the blood thinner despite knowing it could cause fatal bleeding in some patients, and failing to adequately warn that there was no readily-available antidote for Pradaxa bleeding. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

Alleged victims of Pradaxa bleeding may be entitled to compensation for their medical bills, lost wages, pain and suffering and more. Read More about Pradaxa side effects at Bernstein Liebhard LLP’s website. To arrange for a free legal consultation, please call 800-511-5092.

*nejm.org/doi/full/10.1056/NEJMoa1300615, NEJM, September 1, 2013
**bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html, Bloomberg.com, December 11, 2012
***ismp.org/quarterwatch/pdfs/2012Q2.pdf, QuarterWatch, January 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.pradaxalawsuithelp.com/

Read the full story at http://www.prweb.com/releases/pradaxa-lawsuit/pradaxa-bleeding/prweb11100071.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pradaxa Bleeding Lawyers at Wright & Schulte LLC Note Growing Number of Filings in Federal Multidistrict Litigation Established for Pradaxa Lawsuits
2. Pradaxa Lawsuit News: Bernstein Liebhard LLP Comments on Boehringer Ingelheim’s Application to Expand Approved Uses for Pradaxa
3. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal Pradaxa Bleeding Litigation
4. Pradaxa Lawsuit Lawyers at Wright & Schulte LLC Disturbed by New Study Finding that Pradaxa Users Face Significantly Higher Risk of Bleeding Side-Effects
5. DrugRisk Update: Court Issues Latest Decision in Pradaxa Bleeding Litigation
6. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Scheduling of Next Case Management Conference in Federal Pradaxa Bleeding Litigation
7. Doyle Raizner Pradaxa Case Chosen for Bellwether Early Trial Consideration
8. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Bleeding Litigation
9. DrugRisk Update: New Study Warns of Pradaxa Dangers as Lawsuits Increase
10. Pradaxa Lawsuit Attorneys at Wright & Schulte LLC Report on Scheduling of Bellwether Trials in Federal Pradaxa Bleeding Lawsuits
11. Pradaxa Lawsuit News: Bernstein Liebhard LLP Notes New Study Linking Pradaxa to Increased Heart Attack Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 23, 2017 , ... The TouchPoint Solution, ... who entered metrics into the product’s app. The data replicates and validates ... that within just 30 seconds of using Buzzies, people experienced a 74 percent ...
(Date:1/24/2017)... ... January 23, 2017 , ... ... a new plugin that allows sleep centers to automatically connect and initialize all ... a thin client browser plugin is quickly installed on first use and then ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... week at a new domain address. Alpine Springs Rehabilitation & Recovery Center’s new ... debuted a new logo along with its redesigned and retooled website. The treatment ...
(Date:1/23/2017)... Palo Alto, CA (PRWEB) , ... ... ... Translations, a provider of translation and localization services for life science companies, ... testing and inspection organization, TÜV SÜD America. ISO 17100 is the globally ...
(Date:1/23/2017)... ... January 23, 2017 , ... DMG ... Innovations with Ed Begley, Jr., scheduled to broadcast Saturday, January 28, 2017 at ... was founded in 2008 to address the limitations of fatigue monitoring technologies within ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 23, 2017  Allergan plc, (NYSE: AGN ), ... of the International Headache Academy (IHA). Designed to inspire a ... scientists, IHA offers a three-day, intensive overview on research and ... been the sole sponsor since the inception of IHA in ... in Europe in 2014. ...
(Date:1/23/2017)...  Using Astute Medical,s NephroCheck Test ... kidney injury (AKI) after open-heart surgery and providing ... significantly improved outcomes by reducing the occurrence ... percent, according to a study published ... Medicine. Experience the interactive Multimedia ...
(Date:1/23/2017)... YORK , January 23, 2017 ... Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX ), Sophiris Bio ... MNTA ), and Agile Therapeutics Inc. (NASDAQ: ... sector which turned somewhat lower in late trade on Friday, ... Index dropping about 0.3%, while shares of health care companies ...
Breaking Medicine Technology: